Straits Times Index
3,041.29 -79.29 (-2.54%) S&P 500
4,567.00 -88.27 (-1.90%) Dow
34,483.72 -652.22 (-1.86%) Nasdaq
15,537.69 -245.14 (-1.55%) BTC-USD
57,023.32 -1,287.75 (-2.21%) CMC Crypto 200
1,456.96 +14.18 (+0.98%)
DiaMedica Therapeutics Inc. (DMAC)
| Previous close | 3.6300 |
| Open | 3.6000 |
| Bid | 3.6600 x 900 |
| Ask | 3.9000 x 900 |
| Day's range | 3.5800 - 3.8700 |
| 52-week range | 3.0000 - 10.8800 |
| Volume | |
| Avg. volume | 199,666 |
| Market cap | 98.883M |
| Beta (5Y monthly) | 2.34 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.7720 |
| Earnings date | 10 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 18.20 |
- Business Wire
DiaMedica Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
MINNEAPOLIS, November 17, 2021--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that Rick Pauls, President and CEO, will participate in a fireside chat at the upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference. Management will also be available for one-on-one meetings.
- Business Wire
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2021 Financial Results
MINNEAPOLIS, November 10, 2021--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and financial results for the quarter ended September 30, 2021. Management will host a conference call Thursday, November 11, 2021, at 7:00AM Central Time/8:00AM Eastern Time to discuss its business update and third quarter financial results.
- Business Wire
DiaMedica Therapeutics to Attend the 12th Annual Craig-Hallum Alpha Select Conference November 16, 2021
MINNEAPOLIS, November 09, 2021--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that it will be participating in the 12th Annual Craig-Hallum Alpha Select Conference being held virtually on Tuesday, November 16, 2021. Management will be available to participate in one-on-one meetings. Investors and attendees that would like to schedule a meeting with DiaMe
